Archives

Regenxbio, a Maryland biotechnology company that has its research operations in Philadelphia, signed an exclusive worldwide license agreement with Biogen. The deal gives Biogen, the [...]

      Several firms developing so-called gene therapies are working on a new payment model that rewards them for the long-term performance of their medicines. MAY 16, 2016 Biogen [...]

This year brings the 50th anniversary of the full deciphering of the genetic code — the four-billion-year-old cipher by which DNA’s information is translated and expressed — and the centenary of [...]